公司简介

ABOUT US

Efung Capital is one of the earliest private equity investment institutions developing venture capital businesses specializing in healthcare industry investment. Efung is composed of a high-caliber management team and an experienced investment team consisting of MDs/PhDs who graduated from top universities all over the world. For years, Efung Capital has been consistently pursuing the long-term value of biopharmaceuticals and high-end medical devices, including over 80 investment companies globally, such as Chipscreen Bioscience, Frontier Biotech, Ascentage Pharma, Lifotronic Technology, OBiO Technology , ASIERIS MediTech, 3D Medicines and Harbour BioMed et al. 


We have demonstrated a solid track record and achieved strong revenue and earnings growth. Efung capital was recognized as“Zero2IPO Group2022 Best Healthcare Investment Institution TOP30, Zero2IPO Group 2022 Top 100 China Venture Capital Firms , China Venture2022 Top30 China Venture Capital Firms ,China Venture 2020 Best Healthcare Investment Institution TOP30,China Venture 2019 Best Exit Cases TOP10and The Most Dynamic Pharmaceutical VC Institutions in China.”. Additionally, it has been elected“Shenzhen TOP10 VC Institutions”for several consecutive years and once was theme covered by Nature magazine. 


Why choose us?

为什么选择我们

创业板首家生态环境建设上市公司
中国生态修复和环境建设领军企业
国家级高新技术企业
中国环保产业骨干企业

Our histoty

发展历史

< >
  • 公司简介
  • 企业文化
  • 资质荣誉
  • 发展历程
    • Aboutus
      Aboutus
      Efung Capital is one of the earliest private equity investment institutions developing venture capital businesses specializing in healthcare industry investment. Efung is composed of a high-caliber management team and an experienced investment team consisting of MDs/PhDs who graduated from top universities all over the world. For years, Efung Capital has been consistently pursuing the long-term value of biopharmaceuticals and high-end medical devices, including over 80 investment companies globally, such as Chipscreen Bioscience, Frontier Biotech, Ascentage Pharma, Lifotronic Technology, OBiO Technology , ASIERIS MediTech, 3D Medicines and Harbour BioMed et al. We have demonstrated a solid track record and achieved strong revenue and earnings growth. Efung capital was recognized as“Zero2IPO Group2022 Best Healthcare Investment Institution TOP30, Zero2IPO Group 2022 Top 100 China Venture Capital Firms , China Venture2022 Top30 China Venture Capital Firms ,China Venture 2020 Best Healthcare Investment Institution TOP30,China Venture 2019 Best Exit Cases TOP10and The Most Dynamic Pharmaceutical VC Institutions in China.”. Additionally, it has been elected“Shenzhen TOP10 VC Institutions”for several consecutive years and once was theme covered by Nature magazine.
温庚金 总经理

高级景观设计师

城市立体绿化专家

在城市立体绿化领域深耕多年,曾获立体绿化发明专利1项,世界屋顶绿化协会颁发的立体绿化设计与施工资格证书和空中花园建造师专业委员会委员证书,中国风景园林学会科技进步二等奖以及深圳市科技创新委员会颁发的关于《墙面绿化集成新技术研究》成果奖。
Our honor
资质荣誉 +
Address: 505 China Resources Building, 2666 Keyuan South Road, Nanshan District, Shenzhen
TEL:0755-8831-6141
E-mail:info@efungcapital.com
Copyright ©2018 - 2021 Shenzhen Efung Investment Management Co. Ltd.
Rhino Cloud provides enterprise cloud services
犀牛云提供云计算服务